For: | Rani B, Cao Y, Malfettone A, Tomuleasa C, Fabregat I, Giannelli G. Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma. World J Gastroenterol 2014; 20(15): 4128-4140 [PMID: 24764651 DOI: 10.3748/wjg.v20.i15.4128] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i15/4128.htm |
Number | Citing Articles |
1 |
Yi Jin, Dayue Tong, Junjie Shen, Jianyong Yang, Jiaping Li. Establishment of experimental implantation tumor models of hepatocellular carcinoma in Wistar rats. Tumor Biology 2014; 35(9): 9079 doi: 10.1007/s13277-014-2161-0
|
2 |
Zhen Lu, Yun-Hong Xia, Min Zhao, Bing Zhang, Wen-Ting Dai, Lu Ding, Li-Xia Hu, Jin-Ling Bi, Guo-Lin Jiang. DlgR2 knockdown boosts dendritic cell activity and inhibits hepatocellular carcinoma tumor in-situ growth. Oncotarget 2017; 8(33): 54993 doi: 10.18632/oncotarget.18990
|
3 |
M. Bouattour, E. Raymond, S. Faivre. Carcinome hépatocellulaire : nouveaux concepts, nouvelles molécules et nouvelles approches. Oncologie 2017; 19(5-6): 168 doi: 10.1007/s10269-017-2712-2
|
4 |
Jingwen Luo, Xu-Qiao Chen, Ping Li. The Role of TGF-β and Its Receptors in Gastrointestinal Cancers. Translational Oncology 2019; 12(3): 475 doi: 10.1016/j.tranon.2018.11.010
|
5 |
Yun-Hong Xia, Zhen Lu, Min Zhao, Wen-Ting Dai, Lu Ding, Li-Xia Hu, Guo-Lin Jiang. Tumor-specific hepatic stellate cells (tHSCs) induces DIgR2 expression in dendritic cells to inhibit T cells. Oncotarget 2017; 8(33): 55084 doi: 10.18632/oncotarget.19027
|
6 |
Rui Peng, Guang-Xi Zhao, Jing Li, Yu Zhang, Xi-Zhong Shen, Ji-Yao Wang, Jian-Yong Sun. Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 <i>in vivo</i>. World Journal of Gastroenterology 2016; 22(12): 3341-3354 doi: 10.3748/wjg.v22.i12.3341
|
7 |
Meng-Hsien Chuang, Jinghua Tsai Chang, Li-Jin Hsu, Ming-Shiou Jan, Fung-Jou Lu. Antitumor Activity of the Chinese Medicine JC-001 Is Mediated by Immunomodulation in a Murine Model of Hepatocellular Carcinoma. Integrative Cancer Therapies 2017; 16(4): 516 doi: 10.1177/1534735416664173
|
8 |
Heeva Baharlou, Nicolas P. Canete, Anthony L. Cunningham, Andrew N. Harman, Ellis Patrick. Mass Cytometry Imaging for the Study of Human Diseases—Applications and Data Analysis Strategies. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02657
|
9 |
Yaojie Fu, Shanshan Liu, Shan Zeng, Hong Shen. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1396-4
|
10 |
Alvin Man Lung Chan, Jin Min Cheah, Yogeswaran Lokanathan, Min Hwei Ng, Jia Xian Law. Natural Killer Cell-Derived Extracellular Vesicles as a Promising Immunotherapeutic Strategy for Cancer: A Systematic Review. International Journal of Molecular Sciences 2023; 24(4): 4026 doi: 10.3390/ijms24044026
|
11 |
Isabel Fabregat, Daniel Caballero-Díaz. Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00357
|
12 |
Mona Abd El-Rahman Abu El-Makarem, Douaa Mohammed Sayed, Ragaa Abdelshaheed Matta, Mahmoud Ragab Mohamed, Manal Ameer Abd El-Malak, Nehal Ibrahim Abbas. Interaction of peripheral CD4+CD25+CD127− Tregs with prolactin in HCV hepatocellular carcinoma: oncogenic or immunogenic mechanisms. Egyptian Liver Journal 2023; 13(1) doi: 10.1186/s43066-023-00250-2
|
13 |
Mansooreh Ahmadian, Christian Rickert, Angela Minic, Julia Wrobel, Benjamin G. Bitler, Fuyong Xing, Michael Angelo, Elena W. Y. Hsieh, Debashis Ghosh, Kimberly R. Jordan, Virginie Uhlmann. A platform-independent framework for phenotyping of multiplex tissue imaging data. PLOS Computational Biology 2023; 19(9): e1011432 doi: 10.1371/journal.pcbi.1011432
|
14 |
Liren Qian, Delia Dima, Cristian Berce, Yu Liu, Ioana Rus, Lajos-Zsolt Raduly, Yi Liu, Bobe Petrushev, Ioana Berindan-Neagoe, Alexandru Irimie, Alina Tanase, Ancuta Jurj, Jianliang Shen, Ciprian Tomuleasa. Protein dysregulation in graft versus host disease. Oncotarget 2018; 9(1): 1483 doi: 10.18632/oncotarget.23276
|
15 |
Marcelo M. Rodríguez, Esteban Fiore, Juan Bayo, Catalina Atorrasagasti, Mariana García, Agostina Onorato, Luciana Domínguez, Mariana Malvicini, Guillermo Mazzolini. 4Mu Decreases CD47 Expression on Hepatic Cancer Stem Cells and Primes a Potent Antitumor T Cell Response Induced by Interleukin-12. Molecular Therapy 2018; 26(12): 2738 doi: 10.1016/j.ymthe.2018.09.012
|
16 |
Hiroshi Yasuda, Masatoshi Nakagawa, Hirofumi Kiyokawa, Eisaku Yoshida, Toru Yoshimura, Naohiko Koshikawa, Fumio Itoh, Motoharu Seiki. Unique Biological Activity and Potential Role of Monomeric Laminin-γ2 as a Novel Biomarker for Hepatocellular Carcinoma: A Review. International Journal of Molecular Sciences 2019; 20(1): 226 doi: 10.3390/ijms20010226
|
17 |
Gianluigi Giannelli, Bhavna Rani, Francesco Dituri, Yuan Cao, Giuseppe Palasciano. Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment. Gut 2014; 63(10): 1668 doi: 10.1136/gutjnl-2014-307323
|
18 |
Luciana R. Gomes, Alexandre T. Vessoni, Carlos F.M. Menck. Microenvironment and autophagy cross-talk: Implications in cancer therapy. Pharmacological Research 2016; 107: 300 doi: 10.1016/j.phrs.2016.03.031
|
19 |
Rosanna Scialpi, Valentina Arrè, Gianluigi Giannelli, Francesco Dituri. Laminin-332 γ2 Monomeric Chain Promotes Adhesion and Migration of Hepatocellular Carcinoma Cells. Cancers 2023; 15(2): 373 doi: 10.3390/cancers15020373
|
20 |
Chun-yu Huang, Hua Wang, Wei Liao, Feng Han, Yong-qiang Li, Shu-wei Chen, Xiang-ming Lao. Transforming Growth Factor β is a Poor Prognostic Factor and Inhibits the Favorable Prognostic Value of CD8+ CTL in Human Hepatocellular Carcinoma. Journal of Immunotherapy 2017; 40(5): 175 doi: 10.1097/CJI.0000000000000166
|
21 |
Huisheng Liu, JiaYuan Zhong, JiaQi Hu, ChongYin Han, Rui Li, XueQing Yao, ShiPing Liu, Pei Chen, Rui Liu, Fei Ling. Single-cell transcriptomics reveal DHX9 in mature B cell as a dynamic network biomarker before lymph node metastasis in CRC. Molecular Therapy - Oncolytics 2021; 22: 495 doi: 10.1016/j.omto.2021.06.004
|
22 |
Lunjie Lu, Jun Zhou, Jingying Zhang, Jun Che, Yang Jiao, Yusong Zhang, Shun-Wan Chan. Prevention and Therapeutic Effects and Mechanisms of Tanshinone IIA Sodium Sulfonate on Acute Liver Injury Mice Model. Evidence-Based Complementary and Alternative Medicine 2016; 2016(1) doi: 10.1155/2016/4097398
|
23 |
Dalma Deak, Cristina Pop, Alina-Andreea Zimta, Ancuta Jurj, Alexandra Ghiaur, Sergiu Pasca, Patric Teodorescu, Angela Dascalescu, Ion Antohe, Bogdan Ionescu, Catalin Constantinescu, Anca Onaciu, Raluca Munteanu, Ioana Berindan-Neagoe, Bobe Petrushev, Cristina Turcas, Sabina Iluta, Cristina Selicean, Mihnea Zdrenghea, Alina Tanase, Catalin Danaila, Anca Colita, Andrei Colita, Delia Dima, Daniel Coriu, Hermann Einsele, Ciprian Tomuleasa. Let’s Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02856
|
24 |
Gianluigi Giannelli, Wolfgang Mikulits, Steven Dooley, Isabel Fabregat, Aristidis Moustakas, Peter ten Dijke, Piero Portincasa, Peter Winter, Richard Janssen, Stefano Leporatti, Blanca Herrera, Aranzazu Sanchez. The rationale for targeting TGF‐β in chronic liver diseases. European Journal of Clinical Investigation 2016; 46(4): 349 doi: 10.1111/eci.12596
|
25 |
Francesco Dituri, Rosanna Scialpi, Tannin A. Schmidt, Martina Frusciante, Serena Mancarella, Luigi Giovanni Lupo, Erica Villa, Gianluigi Giannelli. Proteoglycan-4 is correlated with longer survival in HCC patients and enhances sorafenib and regorafenib effectiveness via CD44 in vitro. Cell Death & Disease 2020; 11(11) doi: 10.1038/s41419-020-03180-8
|
26 |
Yuri Miyazoe, Satoshi Miuma, Hisamitsu Miyaaki, Yasuko Kanda, Suguru Nakashiki, Ryu Sasaki, Masafumi Haraguchi, Hidetaka Shibata, Takuya Honda, Naota Taura, Kazuhiko Nakao. Extracellular vesicles from senescent hepatic stellate cells promote cell viability of hepatoma cells through increasing EGF secretion from differentiated THP‑1 cells . Biomedical Reports 2020; doi: 10.3892/br.2020.1279
|
27 |
Tetiana Hourani, Amit Sharma, Rodney B. Luwor, Adrian A. Achuthan. Transforming growth factor-β in tumor microenvironment: Understanding its impact on monocytes and macrophages for its targeting. International Reviews of Immunology 2025; 44(2): 82 doi: 10.1080/08830185.2024.2411998
|
28 |
Florian Cabillic, Anne Corlu. Regulation of Transdifferentiation and Retrodifferentiation by Inflammatory Cytokines in Hepatocellular Carcinoma. Gastroenterology 2016; 151(4): 607 doi: 10.1053/j.gastro.2016.06.052
|
29 |
Jamie L. Hernandez, Jaehyung Park, Shan Yao, Anna K. Blakney, Hienschi V. Nguyen, Bob H. Katz, Jeffrey T. Jensen, Kim A. Woodrow. Effect of tissue microenvironment on fibrous capsule formation to biomaterial-coated implants. Biomaterials 2021; 273: 120806 doi: 10.1016/j.biomaterials.2021.120806
|
30 |
Helena Degroote, Sander Lefere, Astrid Vandierendonck, Bart Vanderborght, Tim Meese, Filip Van Nieuwerburgh, Xavier Verhelst, Anja Geerts, Hans Van Vlierberghe, Lindsey Devisscher. Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models. Oncotarget 2021; 12(6): 562 doi: 10.18632/oncotarget.27906
|
31 |
Roman A. Anisimov, Dmitry A. Gorin, Anatolii A. Abalymov. 3D Cell Spheroids as a Tool for Evaluating the Effectiveness of Carbon Nanotubes as a Drug Delivery and Photothermal Therapy Agents. C 2022; 8(4): 56 doi: 10.3390/c8040056
|
32 |
Francesco Dituri, Gianluigi Gigante, Rosanna Scialpi, Serena Mancarella, Isabel Fabregat, Gianluigi Giannelli. Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular Carcinoma. Cancers 2022; 14(8): 1902 doi: 10.3390/cancers14081902
|